Rodica Morariu-Zamfir, MD

Trials

Studies that name Rodica Morariu-Zamfir, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:33 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT03721965 · Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects

  Incyte Corporation · terminated · Acute Graft-versus-host Disease · study director
• Ph2/Ph3
  NCT03584516 · GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

  Incyte Corporation · terminated · Chronic Graft-versus-host Disease · study director
• Ph1
  NCT03497273 · Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

  Incyte Corporation · completed · Acute Graft-versus-host Disease · study director
• Ph1
  NCT03320642 · GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

  Incyte Corporation · terminated · Hematologic Malignancies · study director
• Ph3
  NCT03139604 · GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease

  Incyte Corporation · completed · Graft-versus-host Disease (GVHD) · study director
• Ph1
  NCT02614612 · Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

  Incyte Corporation · completed · Graft-versus-host Disease (GVHD) · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.